Eli Lilly and Company
AMINOTHIAZINIES AND THEIR USE AS BACE1 INHIBITORS
Last updated:
Abstract:
The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treatment of neurodegenerative diseases and disorders, such as Alzheimer's disease. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
2 Aug 2017
Issue date:
18 Nov 2021